Terns Pharmaceuticals, Inc. Detailed Financials

Full historical quarterly statements

Metric2025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Total Revenue00000000
Cost of Goods Sold-108K0108K00000
Gross Profit108K0-108K00000
R&D Expenses18.9M19.9M20.4M18.7M18.0M15.2M18.4M18.6M
Operating Expenses27.7M27.7M27.3M27.4M25.9M24.9M25.5M25.4M
Operating Income-27.6M-27.7M-27.4M-27.4M-25.9M-24.9M-25.5M-25.4M
Other Income / Gains4.4M3.1M3.4M3.6M4.2M3.1M2.9M3.2M
Net Income-23.6M-24.6M-24.1M-23.9M-21.8M-21.9M-22.7M-22.4M
EPS (Diluted)-0.24-0.27-0.26-0.26-0.24-0.28-0.31-0.30
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio00000000
General And Administrative Expenses8.7M7.8M7.0M8.7M7.9M9.8M7.2M6.9M
Selling And Marketing Expenses00000000
Selling General And Administrative Expenses8.7M7.8M7.0M8.7M7.9M9.8M7.2M6.9M
Other Expenses108K0-108K00000
Cost And Expenses27.6M27.7M27.4M27.4M25.9M24.9M25.5M25.4M
Interest Income4.5M3.1M3.4M3.6M4.1M3.1M2.9M3.2M
Interest Expense00000000
Depreciation And Amortization-289K12K108K169K214K206K240K236K
Ebitda-34.4M-24.6M-23.9M-27.3M-25.7M-24.7M-25.3M-25.2M
Ebitdaratio00000000
Operating Income Ratio00000000
Income Before Tax-23.2M-24.6M-24.0M-23.8M-21.8M-21.9M-22.7M-22.3M
Income Before Tax Ratio00000000
Income Tax Expense383K46K64K88K40K62K61K97K
Net Income Ratio00000000
Epsdiluted-0.24-0.27-0.26-0.26-0.24-0.28-0.31-0.30
Weighted Average Shs Out93.2M91.7M91.6M91.5M91.2M77.8M74.5M74.4M
Weighted Average Shs Out Dil93.2M91.7M91.6M91.5M91.2M77.8M74.5M74.4M